Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05885542 · ClinicalTrials.gov registry record · Phase 1
SCORE Emerging Adult Cannabis Use & Stress
A Phase 1 study of Cannabis Use Disorder, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 148
- Enrollment target
- 1
- Study location
NCT05885542 is a Phase 1 study of Cannabis Use Disorder that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 148 participants, above the 105-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05885542, a Phase 1 study of Cannabis Use Disorder, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 148 participants
- Enrollment target
- 1
- Study location
Study Summary
The interface between cannabis use and stress is a particularly important focus for sex differences research in emerging adults. Given the dynamics at play in this critical stage when cannabis use is most prevalent, developmentally informed research is needed to guide tailored clinical interventions. This study will apply rigorous and innovative methods to elucidate sex differences in the nexus of cannabis use and stress among emerging adults with cannabis use disorder to guide the development of tailored treatments.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Cannabidiol oral solution
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2028-07-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05885542
The ClinicalTrials.gov registry entry for NCT05885542 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 105-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (41% higher). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cannabis Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05885542 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT05885542 about?
NCT05885542 is a clinical study titled "SCORE Emerging Adult Cannabis Use & Stress". The interface between cannabis use and stress is a particularly important focus for sex differences research in emerging adults. Given the dynamics at play in this critical stage when cannabis use is most prevalent, developmentally informed research is needed to guide tailored clinical interventions...
What is the current status of trial NCT05885542?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 148 participants. The study started on 2023-11-01. Estimated completion is 2028-07-31.
What conditions does trial NCT05885542 study?
This clinical trial studies the following conditions: Cannabis Use Disorder.
What interventions are being tested in trial NCT05885542?
The interventions under investigation include: Placebo (DRUG), Cannabidiol oral solution (DRUG).
Who is sponsoring clinical trial NCT05885542?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05885542 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Psilocybin-assisted Treatment for Cannabis Use Disorder
RECRUITING · Phase 1
-
Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use
RECRUITING · Phase 1
-
Mitigating PTSD-CUD After Sexual Assault
RECRUITING · Phase 1
-
Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans
RECRUITING · Phase 1
-
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
COMPLETED · Phase 1
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.